在阳性夜间血红蛋白尿症中补充抑制:从生物学到治疗
Francesco Versino1,2, Bruno Fattizzo1,2
1Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
International journal of laboratory hematology
|April 16, 2024
概括
补充抑制剂,包括抗C5疗法,是 Paroxysmal 夜间血红蛋白尿 (PNH) 的关键. 新的上游抑制剂提供了改善的贫血控制,但坚持和突破性血液溶解等挑战仍然存在,指导精确医学的未来.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性夜间血红蛋白尿 (PNH) 主要通过补充抑制剂进行管理,特别是像eculizumab这样的抗C5单克隆抗体.
- 虽然有效,但eculizumab需要终身静脉注射,并且可能导致由于血液溶解控制不完整或血管外血液溶解 (EVH) 导致显著患者亚组的亚最佳反应.
研究的目的:
- 审查PNH的生理病理学,临床表现和诊断方法.
- 描述目前可用的和新兴的针对PNH的补充抑制剂,评估它们的疗效,施用途径,以及准确医学策略的潜力.
主要方法:
- 对PNH病理生理学和补充抑制机制的现有文献的审查.
- 对新型抗C5,抗C3,抗B因子和抗D因子药物在PNH治疗中的临床试验数据的分析.
主要成果:
- 拉武利祖马布是一种更长效的抗C5药物,增强了方便性,并减少了药理学突破性血液溶解 (BTH).
- 上游抑制剂 (抗C3,抗B因子,抗D因子) 有效地向EVH,改善了抗C5低最佳反应者的贫血和输血需求,尽管口服药物存在坚持方面的考虑.
- 反C5和上游抑制剂都不能完全解决因感染或手术引发的药理学BTH.
结论:
- 多种补充抑制剂的开发为PNH提供了准确医学的途径,根据个体患者的需要和疾病特征量身定制治疗.
- 尽管取得了进展,但与管理方便,遵守和管理BTH事件相关的挑战仍然是PNH管理的关键未满足需求.
相关概念视频
01:36Humoral Immune Responses
72.7K
Overview
72.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689
01:23Antimicrobial Proteins
984
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
984
01:24Disorders of Hemostasis
881
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
881
01:26Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K